The nation of Zimbabwe has turned down a major US health deal valued at $367m (£272m) spanning five years because of Washington's request for confidential data.
The decision came to light after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative later stated that the US was requesting genetic material for scientific study and profit while refused to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to find a deal agreeable to all parties so the nation's vital HIV programme can continue.
Wider Context
Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and accountability.
Based on statements, Sixteen nations in Africa have to date signed similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the basic resources for medical research with no certainty that the resulting innovations would be accessible to our population if a future pandemic arise."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting systems previously established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.
"This mechanism is designed to ensure that when a nation provides its samples, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to create them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We encourage continued dialogue with our American counterparts on how subsequent collaboration might be structured in a way that honours the independence and interests of both nations."
Medical Community Reaction
A leading public health body expressed it acknowledged the official position, but urged that talks should continue considering much of the nation's HIV programmes were funded by international support.
"If technical issues exist, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group commented.
The situation emphasises the ongoing challenges between receiving vital foreign assistance and protecting national sovereignty in an ever more interconnected world.